The number of infected people in Maharashtra rose to 19,373,754 on Saturday after 32,226 new cases of coronavirus infection. The Department of Health provided this information. The death toll in the state rose to 49,6331 after 51 more patients died from the epidemic at the same time, the department said.
The department said in a statement that after releasing another 2,110 people from the hospital, the total number of people rescued in the state rose to 17,33,935. At present 53,137 patients are undergoing treatment in the state. At the same time, the total number of infected people rose to 2,94,660 after 593 new cases of infection were reported in Mumbai. At the same time, the death toll rose to 11,132 after seven more patients died from the infection.
Recommendation for ‘covaxine’ approval for emergency use
Meanwhile, an expert committee of the Central Medicine Authority of India on Saturday recommended the approval of the home-developed Covid-19 vaccine ‘Kovacin’ for emergency use with certain conditions. On Friday, the Central Drugs Standards Control Organization’s (CDSCO) Cowid-19 subject matter expert committee (SEC) recommended approval for emergency use of the coronavirus vaccine in Oxford for emergency use in India. In collaboration with the Indian Council of Medical Research (ICMR), India Biotech has developed covaxin domestically.
The vaccine from a Hyderabad-based pharmaceutical firm was reconsidered on Saturday after a submission was handed over to the CDSC’s Committee of Experts (SEC) on Covid-19 for emergency use, sources said. In December, India Biotech filed an application with the Comptroller General of India Pharmaceuticals (DCGI) for approval of the domestically developed covacin vaccine. The SEC on Friday recommended the approval of the Oxford-Astrageneca anti-coronavirus vaccine ‘Covishield’ for emergency use in India.